[HIV: what's new in 2024].

Emeline Gauthiez, Micol Pallanza, Matthias Cavassini, Alexandra Calmy
{"title":"[HIV: what's new in 2024].","authors":"Emeline Gauthiez, Micol Pallanza, Matthias Cavassini, Alexandra Calmy","doi":"10.53738/REVMED.2025.21.900-1.85","DOIUrl":null,"url":null,"abstract":"<p><p>The year 2024 saw many advances in HIV care, both in terms of treatment and prevention. The cure of a patient from Geneva made headlines and helped in understanding the complex immunology of the HIV virus. Long-acting injectable treatments improve the quality of life of peoplewith HIV (PWHIV) and area promising option for pre-exposure prophylaxis (PreP). Primary cardiovascular prevention in PLWHIV is improving, and therapeutic options have increased for pregnant and breastfeeding women living with HIV. Those advances must encourage us to insist on open discussions with our patients regarding their risk of acquiring HIV and their eligibility for PreP, and on the importance of early testing and treatment in case of infection.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 900-1","pages":"85-89"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue medicale suisse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53738/REVMED.2025.21.900-1.85","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The year 2024 saw many advances in HIV care, both in terms of treatment and prevention. The cure of a patient from Geneva made headlines and helped in understanding the complex immunology of the HIV virus. Long-acting injectable treatments improve the quality of life of peoplewith HIV (PWHIV) and area promising option for pre-exposure prophylaxis (PreP). Primary cardiovascular prevention in PLWHIV is improving, and therapeutic options have increased for pregnant and breastfeeding women living with HIV. Those advances must encourage us to insist on open discussions with our patients regarding their risk of acquiring HIV and their eligibility for PreP, and on the importance of early testing and treatment in case of infection.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[艾滋病:2024年的新动向]。
2024 年,艾滋病毒护理在治疗和预防方面都取得了许多进展。日内瓦一名患者的治愈成为头条新闻,有助于人们了解艾滋病毒复杂的免疫学。长效注射疗法提高了艾滋病毒感染者(PWHIV)的生活质量,并为暴露前预防(PreP)提供了有前途的选择。艾滋病病毒感染者心血管疾病的初级预防正在得到改善,感染艾滋病病毒的孕妇和哺乳期妇女的治疗选择也有所增加。这些进步必须鼓励我们坚持与患者公开讨论他们感染 HIV 的风险和接受暴露前预防治疗的资格,以及感染后早期检测和治疗的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Revue medicale suisse
Revue medicale suisse Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
1210
期刊介绍: Destinée aux professionnels de santé, la plateforme revmed.ch regroupe la version électronique de la Revue Médicale Suisse et les applications de formation et d"aide à la prise de décision eRMS. La eRMS est le fruit d’une large collaboration entre institutions et praticiens de Suisse romande.
期刊最新文献
[2024 scientific breakthroughs in ambulatory general internal medicine]. Image en dermato. [Addiction : what's new in 2024]. [Cardiology. Heart failure, cardiac imaging, congenital heart diseases, and cardio-oncology]. [Nutrition-obesity. New therapeutic education programme for migrant and allophone people living with obesity].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1